Pricing Log in Create free account

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR (CUVL) vs Lineage Cell Therapeutics, Inc. (LCTX)

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Lineage Cell Therapeutics, Inc. are both Biotechnology companies. Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Lineage Cell Therapeutics, Inc. are of similar size ($258.0M and $257.5M).

Valuation

Metric CUVL LCTX Biotechnology median
P/E — n/m 10.60
P/S — 19.45 9.40
P/B — 4.26 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — 15.57 9.02
Earnings yield — (14.10%) (32.88%)
Free cash flow yield — (9.58%) (23.13%)

Profitability

Metric CUVL LCTX Biotechnology median
Gross margin — 99.46% 68.51%
Operating margin — (205.23%) 0.00%
Net margin — (246.58%) 0.00%
Free cash flow margin — (186.43%) 0.00%
Return on equity — (60.35%) (51.96%)
Return on assets — (32.75%) (46.06%)
Return on invested capital — (186.79%) 0.00%

Growth

Metric CUVL LCTX Biotechnology median
Revenue growth (TTM) — 19.87% 6.76%
EPS growth (last fiscal year) — (211.11%) 29.88%
Revenue growth, 5-year CAGR — 51.46% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUVL LCTX Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 6.61 4.97
Net debt to EBITDA — 2.64 1.01

Dividend

Metric CUVL LCTX Biotechnology median
Dividend yield 0.56% — 0.41%
Payout ratio — — —

Size

Metric CUVL LCTX Biotechnology median
Market cap 257.50m 257.97m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack